Literature DB >> 6415744

Naloxone fails to reverse hypnotic alleviation of chronic pain.

D Spiegel, L H Albert.   

Abstract

The hypothesis that the alleviation of chronic pain with hypnosis is mediated by endorphins was tested. Six patients with chronic pain secondary to peripheral nerve irritation were taught to control the pain utilizing self-hypnosis. Each subject was tested at 5-min intervals during four 1-h sessions for the amount of reduction of pain sensation and suffering associated with hypnosis while being given, in a random double-blind crossover fashion, an IV injection of either 10 mg naloxone or a saline placebo through an indwelling catheter. The patients demonstrated significant alleviation of the pain with hypnosis, but this effect was not significantly diminished in the naloxone condition. These findings contradict the hypothesis that endorphins are involved in hypnotic analgesia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415744     DOI: 10.1007/BF00429008

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients.

Authors:  Ulf Lindblom; Richard Tegnér
Journal:  Pain       Date:  1979-08       Impact factor: 6.961

2.  The reliability of a linear analogue for evaluating pain.

Authors:  S I Revill; J O Robinson; M Rosen; M I Hogg
Journal:  Anaesthesia       Date:  1976-11       Impact factor: 6.955

3.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone.

Authors:  D J Mayer; D D Price; A Rafii
Journal:  Brain Res       Date:  1977-02       Impact factor: 3.252

5.  Reversal of hypnosis-induced analgesia by naloxone.

Authors:  J B Stephenson
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

6.  Opiate antagonism fails to reverse hypnotic-induced analgesia.

Authors:  H A Nasrallah; T Holley; D S Janowsky
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

7.  Hypnotic analgesia in conditions of stress is partially reversed by naloxone.

Authors:  M Frid; G Singer
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

8.  Biochemistry of pain relief with intracerebral stimulation. Few facts and many hypotheses.

Authors:  B A Meyerson
Journal:  Acta Neurochir Suppl (Wien)       Date:  1980

9.  Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation.

Authors:  H Akil; D E Richardson; J Hughes; J D Barchas
Journal:  Science       Date:  1978-08-04       Impact factor: 47.728

10.  Failure of the opiate antagonist naloxone to modify hypnotic analgesia.

Authors:  A Goldstein; E R Hilgard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

View more
  2 in total

1.  Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Authors:  J J Lipman; B E Miller; K S Mays; M N Miller; W C North; W L Byrne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Effectiveness of Hypnoanalgesia in Paediatric Dermatological Surgery.

Authors:  Peláez Pérez Juana María; Sánchez Casado Marcelino; Quintana Díaz Manuel; Benhaiem Jean Marc; Escribá Alepuz Francisco Javier
Journal:  Children (Basel)       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.